Sands Capital Life Sciences Pulse Fund II, L.P.

13F Holdings History for Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value (IKT)

Symbol: IKT on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value
Latest Disclosed Ownership: 11M shares
Security Ownership: 14.7%

Sands Capital Life Sciences Pulse Fund II, L.P. ownership in Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value (IKT)

2025-08-13 - Sands Capital Life Sciences Pulse Fund II, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 11M shares of Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value (IKT). This represents 14.7% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Sands Capital Life Sciences Pulse Fund II, L.P.	14.7%		$18.4M	11M			$1.68	13G/A	6/30/2025	13 Aug 2025 11:17:42